Abstract:Dysregulations in metabolic and physiological cellular processes are generally accompanied by changes in concentration profiles of multiple biomarkers. Measuring dynamic changes in concentrations of several affected biomarkers can enhance our comprehension of the underlying disease pathophysiology and/or mechanisms of cytotoxicity. Most analytical detection techniques require samples to be obtained at pre-defined times for offline analysis. However, the inadequate temporal resolution of these methods can lead to key biological events that occur at shorter timescales, being overlooked. Electrochemical biosensors are relatively simple, cost-effective detection techniques that have been used extensively for continuous analyte monitoring, and more recently, for sensing multiple analytes. We describe the design and functionality of a novel electrochemical detection platform, comprising a screen-printed Pt electrode array, a microfluidic chip, and an automated pump and valve system, capable of quantitatively detecting up to eight analytes. As a proof of concept, we show the simultaneous, sensitive, and selective amperometric detection of four essential biomarkers- glucose, lactate, glutamate, and acetylcholine, in real time. We also demonstrate the biological application of this platform by continuously monitoring exocytotic glutamate release from human induced pluripotent stem cell-derived neuronal cultures over time. Excessive accumulation of glutamate in the synaptic cleft leads to prolonged stimulation of glutamate receptors on neurons, triggering a cascade of neurotoxic events that ultimately results in loss of neuronal function and cell death. The results suggest that our multianalyte electrochemical sensor platform can be coupled with more complex biological systems such as in vitro organotypic models, for the accurate monitoring of biomarker changes during adverse events like acute neurotoxicity and microbial infection.

Ultradense Electrochemical Chip and Machine Learning for High-Throughput, Accurate Anticancer Drug Screening

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

Application Research of the Microelectronic Cell Sensor in Drug Analysis of Anti-Cancer

Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

Machine Learning-Assisted Automatically Electrochemical Addressable Cytosensing Arrays for Anticancer Drug Screening

(Digital Presentation) Simultaneous and Real-Time Electrochemical Detection of Multiple Biomarkers in a Microfluidic Chip

Ultradense Array of On-Chip Sensors for High-Throughput Electrochemical Analyses

Nanostructured surfaces for analysis of anticancer drug and cell diagnosis based on electrochemical and SERS tools

Application of microfluidic chips in anticancer drug screening

Microfluidic chip for synergic drugs assay in 3D breast cancer cell

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Label-Free, Real-Time Monitoring of Cytochrome C Responses to Drugs in Microdissected Tumor Biopsies with a Multi-Well Aptasensor Platform

Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer Cells

Ultradense Electrochemical Chips with Arrays of Nanostructured Microelectrodes to Enable Sensitive Diffusion-Limited Bioassays

Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring

Development of label-free triboelectric nanosensors as screening platforms for anti-tumor drugs

Selectively cross-linked hydrogel-based cocktail drug delivery micro-chip for colon cancer combinatorial drug screening using AI-CSR platform for precision medicine

Drug screening on digital microfluidics for cancer precision medicine

Printed Electrodes in Microfluidic Arrays for Cancer Biomarker Protein Detection